Previous sessionNext session Extending the evidence-base of opioid substitution treatment Insights zone 4 (I4) In programme Wednesday, 23 October, 2019 - 16:50 to 18:20 View presentations Chair MarsdenJohn King's College LondonUnited Kingdom Keywords StimulantsUser perspectivesOpiatesTreatment: medical/pharmacologicalCrime Presentations Plenary session Poster session Big debate Structured session Workshop Oral presentation session Short communication session Poster guided tour Wednesday, 23 October 17:00 Oral presentation Predictors of treatment allocation guesses in a randomised controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder 17:00 to 17:15 Insights zone 4 (I4) Kirsten Marchand 17:15 Oral presentation Illicit stimulant use in the context of daily injectable opioid agonist treatment: a grounded theory study with patients receiving treatment for severe opioid use disorder in Vancouver, Canada 17:15 to 17:30 Insights zone 4 (I4) Heather Palis 17:30 Oral presentation The effect of entry and retention in opioid substitution therapy on contact with the criminal justice system among opioid dependent people 17:30 to 17:45 Insights zone 4 (I4) Natasa Gisev 17:45 Oral presentation Depot buprenorphine for opioid dependence in prisons in NSW, Australia 17:45 to 18:00 Insights zone 4 (I4) Adrian Dunlop 18:00 Oral presentation Slow release oral morphine versus methadone for the treatment of opioid use disorder: a systematic review and meta-analysis 18:00 to 18:15 Insights zone 4 (I4) Jan Klimas